Apr 25, 2024 / 12:30PM GMT
Operator
Ladies and gentlemen, welcome to the Santera Pharmaceuticals 2023 financial results and corporate update conference call. I am Sandra, the Chorus Call operator. The conference must not be recorded for publication or broadcast.
This conference call may contain certain forward-looking statements based on current assumptions and forecasts made by Santera pharmaceuticals. Such statements involve certain risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of Santera pharmaceuticals.
It will be materially different from those expressed or implied by such statements. These factors include those discussed in the comprehensive risk factor disclosure on the Company website at w. w. with sunterra.com. Sunterra disclaims any obligation to update any forward-looking statements in the conference may be downloaded on Santera's website during the two weeks following the call.
At this time, it's my pleasure to hand over to Mr. Dario Eyquem, CEO. Please go ahead.
Dario Eklund - Santhera
Full Year 2023 Santhera Pharmaceuticals Holding AG Earnings Call Transcript
Apr 26, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers